Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.
Synlogic names COO
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.